摘要:
A medicinal aerosol steroid solution formulation product with enhanced chemical stability. The steroid is a 20-ketosteroid having an OH group at the C-17 or C-21 position and the aerosol container has a non-metal interior surface which has been found to reduce chemical degradation of such steroids.
摘要:
A safety harness with a front D-ring includes an upper body portion and a lower body portion. A front D-ring is positioned at a front of the upper body portion where a first shoulder strap and a second shoulder strap cross. A single length of webbing is used to form a first end of the first shoulder strap, form a first end of the second shoulder strap and connect the front D-ring in a fixed position relative to the first shoulder strap and the second shoulder strap. The single length of webbing is wrapped around a cross-piece of the front D-ring and the first end of the first shoulder strap is formed from a first loop of the single length of webbing sewn together and the second end of the second shoulder strap is formed from a second loop of the single length of webbing sewn together.
摘要:
Development assistance for a program comprising code in more than one language, is provided appropriately for each language in an integrated development environment. The assistance can include syntax highlighting, structure analysis, error reporting, completion assistance and/or context-sensitive help. The language of the subject element of code is determined and the appropriate assistance processes are applied. If the code is in a supplementary language, routines associated with the supplementary language are invoked to provide the assistance. When needed, information from other parts of the program file is provided to determine the appropriate assistance for the element of code.
摘要:
The RF impedance of a metal trace at gigahertz frequencies is reduced by forming the metal trace to have a base region and a number of fingers that extend away from the base region. When formed to have a number of loops, the metal trace forms an inductor with an increased Q.
摘要:
An improved computer-implemented method is disclosed, which maintains a version history of objects in a repository. Modifications to property values and links are tracked with respect to versions of a model. The method includes the steps of maintaining a start version and a list of end versions for each object in the model and maintaining a start version and a list of end versions for each attribute value in the model. Moreover, in response to a request for objects in a class with respect to a current version, only those objects whose start version is in the history of the current version and whose end versions are not in the history of the current version are retrieved. Also, in response to a request for attribute values of an object with respect to a current version, only those values whose start version is in the history of the current version and whose end versions are not in the history of the current version are retrieved.
摘要:
Provided are methods and systems for message transfer between nodes of a communication network which reduce the occurrence of repeated transfer failures associated with a particular message or messages within a batch. When a batch of messages sent from a sender node cannot be stored at a receiver node, the receiver node identifies which messages within the batch caused the rejection and communicates this information to the sender node. The sender node records the destinations of the identified messages in a "destination black list", and then separates messages having these identified problematic destinations from the other messages. The batch of messages is then retransmitted to the receiver, but with the messages which have the identified problematic destinations excluded from the batch. These excluded messages are then dealt with separately without causing repeated rejection of the batch.
摘要:
2-Amino-N-(1,2-diphenyl-1-methylethyl) acetamide (remacemide), or a pharmaceutically acceptable salt thereof, for use in the treatment of Parkinson's disease is disclosed.
摘要:
In a computer system having a user interface, a memory, a repository and a database, a repository program operating in the computer system for accessing the database, the repository program executing a method for supporting modeling, the method comprising the steps of examining a collection of types forming a model; sorting object types into data and persistent type objects; creating all data type objects and adding to a collection of all objects owned by the model; creating all persistent type objects and adding to a collection of all objects owned by the model; initializing all persistent type objects in the collection of objects.
摘要:
The invention provides a method of treating a patient having target cells that express FcyRIIb, the method comprising administering (i) an antibody molecule that specifically binds a surface antigen of the target cell, which antibody molecule has an Fc domain capable of binding FcyRIIb; in combination with (ii) an agent that prevents or reduces binding between the Fc domain of the antibody molecule and FcyRIIb; characterized in that the patient is selected on the basis that their target cells express an elevated level of FcyRIIb.
摘要:
Certain chemical entities are provided herein. Also provided are pharmaceutical compositions comprising at least one chemical entity and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain diseases and disorders responsive to the inhibition of KMO activity are described, which comprise administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are disclosed. These diseases include neurodegenerative disorders such as Huntington's disease. Also described are methods of treatment include administering at least one chemical entity as a single active agent or administering at least one chemical entity in combination with one or more other therapeutic agents. Also provided are methods for screening compounds capable of inhibiting KMO activity.